how many mg ghk cu per day 7% GHK-CU ACCELERANT How Often to Inject GHK-Cu
Description
The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters
2221, National Institutes of Health
Research into its anti-tumour potential in breast and colorectal cancer has been prompted by its alleged antioxidant activities and potential to decrease carcinogenic receptor expression
It is extra work
